Evaluating radiation treatment outcomes for uterine cancer
Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms Treated With Radiotherapy at the Sant'Orsola Polyclinic in Bologna.
IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774482
This study looks at how different radiation treatments for uterine cancer affect patients and their side effects to help make treatments better in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna (other) |
| Drugs / interventions | radiation |
| Locations | 1 site (Bologna) |
| Trial ID | NCT06774482 on ClinicalTrials.gov |
What this trial studies
This observational study collects data on the radiation treatment of uterine neoplasms, including endometrial and cervical cancers. It aims to evaluate tumor response and potential toxicity associated with different dosages, fractionation, and techniques used in radiotherapy. By analyzing a large sample of patients treated since 2000, the study seeks to identify correlations between treatment characteristics and radiation-induced toxicities, ultimately aiming to personalize treatment and improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include female patients aged 18 and older with a new or previous diagnosis of malignant uterine neoplasm treated at the Sant'Orsola Polyclinic.
Not a fit: Patients who choose not to undergo radiation treatment at the Radiotherapy Unit will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better prediction and prevention of radiation-induced toxicities in patients with uterine neoplasms.
How similar studies have performed: While this approach is systematic, similar studies have shown success in evaluating treatment outcomes and toxicities in cancer therapies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patients, aged ≥ 18 years, with a new or previous diagnosis of malignant uterine neoplasm, starting from 01/01/2000, treated at the Radiotherapy Unit of the Sant'Orsola Polyclinic * Obtaining informed consent Exclusion Criteria: * Patients with a new or previous diagnosis of malignant uterine neoplasm who choose not to undergo radiation treatment at the Radiotherapy Unit of the Sant'Orsola Polyclinic
Where this trial is running
Bologna
- IRCCS Azienda Ospedaliero - Universitaria di Bologna — Bologna, Italy (RECRUITING)
Study contacts
- Principal investigator: Alessio Giuseppe Morganti, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Alessio Giuseppe Morganti, MD
- Email: alessio.morganti2@unibo.it
- Phone: +39 0516363136
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Uterine Neoplasms